← Leaderboards
Andrew Flint
Leidos Biomedical Research, Inc.
$5,506,164
Attributed
$5,506,164
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $5.4M · FY2016–18$10M$7.5M$5M$2.5M$0
'16
'17
'18
Funding mix
By agency
NIH$5,506,164 · 1
By mechanism
N01$5,506,164 · 1
Top collaborators
No co-investigators on record.
Most similar at Leidos Biomedical Research, Inc.
Same institution · by research overlap
- David Heimbrook$2,362,140,846
- Leonard Freedman$1,216,107,431
- Ralph Parchment$197,348,011
- Ethan Dmitrovsky$597,515,186
- Lynn Briscoe$495,968,635
Others in their field
Top investigators on “Drug Candidate”
- Lawrence Corey · Fred Hutchinson Cancer Center$300,328,337
- David Heimbrook · Leidos Biomedical Research, Inc.$205,385,400
- Wafaa M. El-Sadr · Columbia University Health Sciences$186,594,706
- Myron S Cohen · Family Health International$186,594,706
- Peter B. Gilbert · Fred Hutchinson Cancer Center$148,466,496
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$97,304,430
Research focus
Drug CandidateDrug DiscoveryBiochemicalAnimalsAnimal EfficacyBiomarker DevelopmentBiomedical ResearchBiophysical PropertiesBiologicalCancer CellBiologyBaseCandidate SelectionCell LineCellsCellular AssayCellular BiologyChip-SeqCalorimetryClustered Regularly Interspaced Short Palindromic RepeatsContractsDivision Of Cancer Treatment And DiagnosisDoseDrug Kinetics